MPCI fundamentals
An in-depth look to MEMPHIS PHARMACEUTICALS operating, investing, and financing activities
MPCI free cash flow for Q4 24 is 54.91 M EGP. For 2024, MPCI free cash flow was 213.8 M EGP and operating cash flow was 238.17 M EGP.
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EGP
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM